A pilot study of thrombophilia among Chinese women with Recurrent miscarriage

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-14004560

Enrollment

Unknown

Registered

2014-04-24

Start date

2014-06-01

Completion date

Unknown

Last updated

2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

women with recurrent miscarriage

Interventions

case series:This study will involve 15 ml blood taking for thrombophilic screening

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) clinical history of at least three early (<12 weeks of gestation) consecutive pregnancy losses; 2) aged between 18 and 40 years; 3) absence of any chromosomal, endocrine, infectious, anatomic, and autoimmune causes for recurrent miscarriage.

Exclusion criteria

Exclusion criteria: Presence of any chromosomal, endocrine, infectious, anatomic, and autoimmune causes for recurrent miscarriage; Incompetence or refuse for informed consent.

Design outcomes

Primary

Measure	Time frame
prevalence of various thrombophillia among the Chinese women with recurrent miscarriage.During 1st visit in our study;	—

Secondary

Measure	Time frame
Protein C, Protein S;Antithrombin III;Lupus anticoagulant and anticardiolipin antibody assay;Result of Factor V mutation,;prothrombin gene mutation;5,10-methylenetetrahydrofolate reductase genes mutation;	—

Countries

China

Contacts

Public ContactDr. Grace Wing Shan KONG

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong

gracekong@cuhk.edu.hk+852 26322996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026